["Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain - ScienceDirect", "SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies ", "Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display ", "Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function ", "Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants ", "Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike ", "A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model ", "Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality ", "A potent neutralizing nanobody against SARS\u2010CoV\u20102 with inhaled delivery potential - Gai - 2021 - MedComm - Wiley Online Library", "AAAS", "Redirecting", "A protective broadly cross-reactive human antibody defines a conserved site of vulnerability on beta-coronavirus spikes ", "RCSB PDB - 7EAN: immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 6D6", "AAAS", "The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates ", "A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration ", "Evolution of antibody immunity to SARS-CoV-2 ", "AAAS", "A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 ", "Broad sarbecovirus neutralization by a human monoclonal antibody ", "AAAS", "The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates ", "AAAS", "Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries ", "Convergent antibody responses to SARS-CoV-2 in convalescent individuals ", "Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies ", "Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2 ", "RCSB PDB - 7DD2: S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.", "AAAS", "Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 ", "", "Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses ", "AAAS", "Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain ", "mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants ", "Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain ", "Single-cell sequencing of plasma cells from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing antibodies to SARS-CoV-2 ", "Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors", "Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants ", "RCSB PDB - 7DPM: Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab", "Potent synthetic nanobodies against SARS-CoV-2 and molecular basis for neutralization ", "Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody ", "CN112094342A - Alpaca source nano antibody combined with SARS-CoV-2RBD ", "RCSB PDB - 7KXK: SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-\"up\"-1-\"down\" conformation", "CN111732655A - RBD-targeted high-neutralization-activity anti-SARS-CoV-2 fully-humanized monoclonal antibody and application thereof ", "CN111825762A - Nano antibody of S protein RBD structure domain of anti SARS-COV-2 virus and its use ", "CN111875700A - Single-chain antibody of anti SARS-COV-2 virus N protein and its use ", "CN111995674A - anti-COVID-19 virus neutralizing antibody mhC3, humanized antibody and application thereof ", "CN112062838A - Neutralizing single-domain antibody for resisting novel coronavirus SARS-Cov-2 and application thereof ", "CN112062840A - Nano antibody based on novel coronavirus S protein and application thereof ", "US10822379B1 - Molecules that bind to SARS-CoV-2 ", "Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite - ScienceDirect", "Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD - ScienceDirect", "LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection ", "CN111848789A - Single chain antibody for resisting SARS-COV-2 virus S protein and its use ", "CN111875701A - Single-chain antibody of SARS-CoV-2 virus and its use ", "CN111909260A - New coronavirus RBD specific monoclonal antibody and application ", "CN111909261A - New coronavirus RBD specific monoclonal antibody and application ", "CN111909262A - New coronavirus RBD specific monoclonal antibody and application ", "CN111909263A - New coronavirus RBD specific monoclonal antibody and application ", "CN111925440A - New coronavirus RBD specific monoclonal antibody and application ", "CN111925441A - New coronavirus RBD specific monoclonal antibody and application ", "CN111925442A - New coronavirus RBD specific monoclonal antibody and application ", "CN111925443A - New coronavirus RBD specific monoclonal antibody and application ", "CN111925444A - New coronavirus RBD specific monoclonal antibody and application ", "Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection ", "Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein ", "High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme ", "A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD ", "Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants ", "Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry ", "Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence ", "A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies ", "Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a na\u00efve human antibody library ", "AAAS", "CN111978395A - Monoclonal antibody against novel coronavirus RBD domain antigen ", "Discovery of nanobodies against SARS-CoV-2 and an uncommon neutralizing mechanism ", "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody ", "SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses ", "Error - Cookies Turned Off", "AAAS", "Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody ", "AAAS", "Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2 ", "SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape ", "Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient ", "Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 ", "AAAS", "Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual ", "AAAS", "Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection - ScienceDirect", "Redirecting", "AAAS", "Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant - ScienceDirect", "Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD ", "Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants ", "Structure-based development of human antibody cocktails against SARS-CoV-2 ", "The antigenic anatomy of SARS-CoV-2 receptor binding domain - ScienceDirect", "Antibody evasion by the P.1 strain of SARS-CoV-2 - ScienceDirect", "Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals ", "Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients\u2019 B Cells - ScienceDirect", "B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV - ScienceDirect", "Fast isolation of sub-nanomolar affinity alpaca nanobody against the Spike RBD of SARS-CoV-2 by combining bacterial display and a simple single-step density gradient selection ", "Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking ", "Broadening a SARS-CoV-1 neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution ", "", "Human single-chain antibodies neutralize SARS-CoV-2 variants by engaging an essential epitope of the spike: a new weapon against COVID-19 ", "Structures of potent and convergent neutralizing antibodies bound to the SARS-CoV-2 spike unveil a unique epitope responsible for exceptional potency ", "Accelerated Antibody Discovery Targeting the SARS-CoV-2 Spike Protein for COVID-19 Therapeutic Potential ", "Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants ", "Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies - ScienceDirect", "A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection ", "Human neutralizing antibodies elicited by SARS-CoV-2 infection ", "Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library - ScienceDirect", "AAAS", "Fragment-based computational design of antibodies targeting structured epitopes ", "Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies ", "RCSB PDB - 7EAM: immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6", "RCSB PDB - 7CR5: Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD", "Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes", "Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 - ScienceDirect", "LY-CoV1404 potently neutralizes SARS-CoV-2 variants ", "A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope ", "Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects ", "Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection ", "Extremely potent human monoclonal antibodies from COVID-19 convalescent patients - ScienceDirect", "Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition ", "Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV - ScienceDirect", "Production of an Anti-Severe Acute Respiratory Syndrome (SARS) Coronavirus Human Monoclonal Antibody Fab Fragment by Using a Combinatorial Immunoglobulin Gene Library Derived from Patients Who Recovered from SARS ", "Figure 2 from 645 Duan.qxp ", "Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11 - ScienceDirect", "Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens - ScienceDirect", "", "A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage - ScienceDirect", "Chicken single-chain variable fragments against the SARS-CoV spike protein - ScienceDirect", "Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection ", "Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect", "A human monoclonal antibody blocking SARS-CoV-2 infection ", "Structural basis for broad coronavirus neutralization ", "Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice - ScienceDirect", "AAAS", "A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes ", "Therapy with a Severe Acute Respiratory Syndrome\u2013Associated Coronavirus\u2013Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters ", "", "Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein ", "Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen ", "Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway", "Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain - ScienceDirect", "Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies", "Sybodies targeting the SARS-CoV-2 receptor-binding domain ", "Evaluation of candidate vaccine approaches for MERS-CoV ", "", "AAAS", "Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse\u00ae - ScienceDirect", "Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus - ScienceDirect", "DEFINE_ME", "", "Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody ", "AAAS", "DEFINE_ME", "WO2016138160 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE", "Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor ", "A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein ", "Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset ", "Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals ", "Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants", "Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient ", "Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2 ", "", "Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice ", "A human SARS-CoV neutralizing antibody against epitope on S2 protein - ScienceDirect", "Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago ", "Rapid generation of potent antibodies by autonomous hypermutation in yeast ", "CN111333722A - SARS-CoV-2 inhibitor and its application ", "CN111423508A - Separated SARS-CoV-2 protein binding molecule for resisting virus infection ", "CN111620945A - Monoclonal antibody or derivative thereof for resisting novel coronavirus ", "CN111647076A - Neutralizing single-domain antibody for resisting novel coronavirus SARS-Cov-2 and application thereof ", "CN111647077A - Novel coronavirus (SARS-COV-2) spike protein binding molecule and application thereof ", "CN111647079A - Neutralizing antibody for resisting novel coronavirus N protein ", "CN111662379A - Antibody for resisting novel coronavirus, preparation method and application ", "CN111690058A - Antibodies with neutralizing activity against coronaviruses and uses thereof ", "CN111690059A - Monoclonal antibody 1D7 for resisting SARS-CoV-2 ", "CN111718411A - Monoclonal antibody 1F2 for resisting SARS-CoV-2 ", "CN111732654A - Monoclonal antibody 1E10 for resisting SARS-CoV-2 ", "CN111778218A - Phage display antibody library and monoclonal antibody aiming at novel coronavirus SARS-CoV-2 obtained based on panning of phage display antibody library ", "CN111793129A - Antibody or antigen binding fragment thereof specifically binding to coronavirus ", "AAAS", "RCSB PDB - 7CDI: Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD", "RCSB PDB - 7CJI: Photosystem II structure in the S1 state", "Development of Multivalent Nanobodies Blocking SARS CoV 2 Infection by Targeting RBD of Spike Protein ", "A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro ", "DEFINE_ME", "An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction ", "A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes ", "Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain ", "Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies ", "Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers ", "SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface ", "Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection ", "Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants ", "Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis - ScienceDirect", "Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2 ", "Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike - ScienceDirect", "Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics ", "Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants ", "DEFINE_ME", "Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection ", "AAAS", "Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies "]